Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$3,594,174
+$499,944 QoQ
Shares Held
14,283
+0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#1,529
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Berger Financial Group, Inc holds $30,167,656 across 8 Drug Manufacturers - General names. ABBV ranks #4 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
39,841 | $10,118,418 | |
| 2 | LLY |
ELI LILLY & Co
|
6,514 | $7,813,087 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
46,072 | $5,820,736 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
14,283 | $3,594,174 | |
| 5 | AMGN |
Amgen Inc
|
3,591 | $1,300,372 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,364 | $1,074,774 | |
| 7 | PFE |
Pfizer Inc
|
9,471 | $228,061 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,784 | $218,034 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,594,174 | 14,283 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $3,094,230 | 14,227 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $3,449,513 | 15,097 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $4,636,588 | 20,025 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $2,633,390 | 14,187 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $2,961,355 | 14,134 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,650,217 | 14,914 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,770,446 | 14,029 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,018,828 | 5,940 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,020,488 | 5,604 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $832,188 | 5,370 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $815,507 | 5,471 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $775,101 | 5,753 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $914,624 | 5,739 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $854,916 | 5,290 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $594,147 | 4,427 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $632,244 | 4,128 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $653,141 | 4,029 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $539,027 | 3,981 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $338,603 | 3,139 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $353,464 | 3,138 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $360,047 | 3,327 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $372,560 | 3,477 | Shares | Sole | 2021-02-02 | |
| No filing history on record for this holder in this stock. | ||||||